Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
RESEARCH TOOLSreports
Holding CRBP?
Track your performance easily
See the Price Targets and Ratings of:
CRBP Analyst Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRBP Stock 12 Month Forecast
Average Price Target
$69.80
▲(313.51% Upside)
| Highest Price Target$76.00 | Average Price Target$69.80 | Lowest Price Target$60.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
11/07/24
RBC Capital
Reiterated
11/07/24
Oppenheimer
Reiterated
11/07/24
Mizuho Securities
Assigned
11/07/24
Wedbush
Initiated
07/29/24
B.Riley Financial
Reiterated
07/15/24
―
LifeSci Capital
―
Buy
―
Reiterated
11/11/24
We are hosng a virtual Fir eside Chat with CEO Pharmaceuc als (Nasdaq: at noon ET to discuss their excing pipeline in obesity and onc ology. We are excited about the opportunies ahead f or Corbus Pharmaceuc als, and we reiterate our OUTPERFORM rang with a $73 PT. During the call we plan to discuss: CRB-701, an an-necn-4 an body drug c onjugate (ADC) being invesg ated in paen ts with advanced solid tumors and high levels of necn-4 e xpression. The Phase 1 trial completed enrollment in October (our note HERE) and topline results are expected in Q1 2025. On the call we plan to discuss expectaons for the topline data in Q1 as well as current thinking on future development plans with the program. CRB-913, a peripherally restricted CB1 receptor inverse agonist being invesg ated for the treatment of obesity.
―
Jefferies
―
Buy
―
Reiterated
09/23/24
Best Analysts Covering Corbus Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy CRBP and Sell After:
1 Month
xxx
Success Rate
5/7 ratings generated profit
Average Return
+14.40%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +14.40% per trade.
3 Months
xxx
Success Rate
5/10 ratings generated profit
Average Return
+4.34%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +4.34% per trade.
1 Year
Success Rate
1/10 ratings generated profit
Average Return
-1.14%
reiterated a buy rating 15 days ago
Copying Jeff Jones's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -1.14% per trade.
2 Years
xxx
Success Rate
1/10 ratings generated profit
Average Return
-30.04%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 10.00% of your transactions generating a profit, with an average return of -30.04% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRBP Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
6
8
12
13
14
Buy
4
5
6
4
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
13
18
17
17
Each month's total comprises the sum of three months' worth of ratings.
CRBP Financial Forecast
CRBP Stock Forecast FAQ
What is CRBP’s average 12-month price target, according to analysts?
Based on analyst ratings, Corbus Pharmaceuticals’s 12-month average price target is $69.80.
What is CRBP’s upside potential, based on the analysts’ average price target?
Corbus Pharmaceuticals has 313.51% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRBP a Buy, Sell or Hold?
Corbus Pharmaceuticals has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is Corbus Pharmaceuticals’s price target?
The average price target for Corbus Pharmaceuticals is $69.80. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $76.00 ,the lowest forecast is $60.00. The average price target represents 313.51% Increase from the current price of $16.88.
The highest analyst price target is $76.00 ,the lowest forecast is $60.00. The average price target represents 313.51% Increase from the current price of $16.88.
What do analysts say about Corbus Pharmaceuticals?
Corbus Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of CRBP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.